Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies (Q71752197)
Jump to navigation
Jump to search
scientific article published on 01 November 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies |
scientific article published on 01 November 1995 |
Statements
Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies (English)
Tu SM
Hossan E
Amato R
Kilbourn R
1 November 1995